Pfizer's Next mRNA Vaccine Candidate Goes Beyond COVID-19

Pfizer (NYSE: PFE) continues to rake in billions of dollars in sales for its messenger RNA (mRNA) COVID-19 vaccine developed with BioNTech (NASDAQ: BNTX). However, the big drugmaker has bigger plans for its mRNA vaccine program. In this Motley Fool Live video recorded on Sept. 29, Motley Fool contributors Keith Speights and Brian Orelli discuss Pfizer's next mRNA vaccine candidate.

Continue reading

Source Fool.com